These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 30680934)
1. Proteomics in Kidney Allograft Transplantation-Application of Molecular Pathway Analysis for Kidney Allograft Disease Phenotypic Biomarker Selection. Marx D; Metzger J; Olagne J; Belczacka I; Faguer S; Colombat M; Husi H; Mullen W; Gwinner W; Caillard S Proteomics Clin Appl; 2019 Mar; 13(2):e1800091. PubMed ID: 30680934 [TBL] [Abstract][Full Text] [Related]
2. Urinary Biomarkers for Kidney Allograft Injury. Jin PH; Sarwal RD; Sarwal MM Transplantation; 2022 Jul; 106(7):1330-1338. PubMed ID: 34982754 [TBL] [Abstract][Full Text] [Related]
3. Proteomics for Biomarker Identification and Clinical Application in Kidney Disease. Chen L; Su W; Chen H; Chen DQ; Wang M; Guo Y; Zhao YY Adv Clin Chem; 2018; 85():91-113. PubMed ID: 29655463 [TBL] [Abstract][Full Text] [Related]
4. Biomarker-Development Proteomics in Kidney Transplantation: An Updated Review. Sirolli V; Piscitani L; Bonomini M Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982359 [TBL] [Abstract][Full Text] [Related]
5. Contribution of Proteomics in Transplantation: Identification of Injury and Rejection Markers. Zubair H; Azim S; Maluf DG; Mas VR; Martins PN Transplantation; 2023 Oct; 107(10):2143-2154. PubMed ID: 36814094 [TBL] [Abstract][Full Text] [Related]
6. Chronic allograft nephropathy in paediatric renal transplantation. Alexander SI; Fletcher JT; Nankivell B Pediatr Nephrol; 2007 Jan; 22(1):17-23. PubMed ID: 16944214 [TBL] [Abstract][Full Text] [Related]
7. Elevated expression levels of ANXA11, integrins β3 and α3, and TNF-α contribute to a candidate proteomic signature in urine for kidney allograft rejection. Srivastava M; Eidelman O; Torosyan Y; Jozwik C; Mannon RB; Pollard HB Proteomics Clin Appl; 2011 Jun; 5(5-6):311-21. PubMed ID: 21591265 [TBL] [Abstract][Full Text] [Related]
8. Protocol graft biopsy in kidney transplantation. Sakai K; Oguchi H; Muramatsu M; Shishido S Nephrology (Carlton); 2018 Jul; 23 Suppl 2():38-44. PubMed ID: 29968403 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations. Chapman JR Kidney Int Suppl; 2005 Dec; (99):S108-12. PubMed ID: 16336561 [TBL] [Abstract][Full Text] [Related]
10. Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods. Johnston O; Cassidy H; O'Connell S; O'Riordan A; Gallagher W; Maguire PB; Wynne K; Cagney G; Ryan MP; Conlon PJ; McMorrow T Proteomics Clin Appl; 2011 Aug; 5(7-8):422-31. PubMed ID: 21751411 [TBL] [Abstract][Full Text] [Related]
11. Application of spatial-omics to the classification of kidney biopsy samples in transplantation. Tasca P; van den Berg BM; Rabelink TJ; Wang G; Heijs B; van Kooten C; de Vries APJ; Kers J Nat Rev Nephrol; 2024 Nov; 20(11):755-766. PubMed ID: 38965417 [TBL] [Abstract][Full Text] [Related]
12. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis. Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738 [TBL] [Abstract][Full Text] [Related]
13. Proteomics: Its Promise and Pitfalls in Shaping Precision Medicine in Solid Organ Transplantation. Farkona S; Pastrello C; Konvalinka A Transplantation; 2023 Oct; 107(10):2126-2142. PubMed ID: 36808112 [TBL] [Abstract][Full Text] [Related]
14. The natural history of chronic allograft nephropathy. Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Allen RD; Chapman JR N Engl J Med; 2003 Dec; 349(24):2326-33. PubMed ID: 14668458 [TBL] [Abstract][Full Text] [Related]
16. Mining the human urine proteome for monitoring renal transplant injury. Sigdel TK; Gao Y; He J; Wang A; Nicora CD; Fillmore TL; Shi T; Webb-Robertson BJ; Smith RD; Qian WJ; Salvatierra O; Camp DG; Sarwal MM Kidney Int; 2016 Jun; 89(6):1244-52. PubMed ID: 27165815 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Potential of Minimally Invasive Biomarkers: A Biopsy-centered Viewpoint From the Banff Minimally Invasive Diagnostics Working Group. Huang E; Mengel M; Clahsen-van Groningen MC; Jackson AM Transplantation; 2023 Jan; 107(1):45-52. PubMed ID: 36508645 [TBL] [Abstract][Full Text] [Related]
19. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application. Mischak H; Delles C; Klein J; Schanstra JP Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772 [TBL] [Abstract][Full Text] [Related]
20. Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. Kurian SM; Heilman R; Mondala TS; Nakorchevsky A; Hewel JA; Campbell D; Robison EH; Wang L; Lin W; Gaber L; Solez K; Shidban H; Mendez R; Schaffer RL; Fisher JS; Flechner SM; Head SR; Horvath S; Yates JR; Marsh CL; Salomon DR PLoS One; 2009 Jul; 4(7):e6212. PubMed ID: 19593431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]